Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly interrupted when a drug executive collapsed while President Donald Trump announced a deal to lower obesity drug prices.
Details of the Incident
The event on Thursday involved President Trump and representatives from Eli Lilly and Novo Nordisk discussing an agreement to expand coverage and reduce prices for the obesity treatments Zepbound and Wegovy.
During the remarks, David Ricks, CEO of Eli Lilly, noticed the executive and asked,
“Are you okay? Gordon, are you okay?”
Response to the Collapse
The individual who fainted was identified as Gordon Findlay, Novo Nordisk's global brand director. Dr. Mehmet Oz immediately assisted as Findlay fell to his knees and lost consciousness.
Health and Human Services Secretary was present at the time and helped manage the situation. The press was then asked to leave.
Aftermath
About 30 minutes later, the press conference resumed, with President Trump providing an update on Gordon Findlay's condition.
“President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help Gordon Findlay of Novo Nordisk, who passed out during the event.”
Summary: During a press event focused on lowering obesity drug prices, Novo Nordisk's Gordon Findlay collapsed, prompting immediate medical help and a temporary pause in the announcement.
Would you prefer a more formal or conversational tone for this text?